Rafael Morales‐Barrera

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

Elena Castro, Nuria Romero-Laorden, Ángela del Pozo et al. · Journal of Clinical Oncology · 2019 · 366 citations · Full text

Smoking and Timing of Cessation

Rafael Morales‐Barrera, Weiji Shi, David Amar et al. · CHEST Journal · 2005 · 254 citations

Tobacco Cessation, Tobacco Control, Health Sciences +9

A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

Karim Fizazi, Aline Maillard, Nicolas Penel et al. · Annals of Oncology · 2019 · 240 citations · Full text

Malignant Disease, Medicine, Phase Iii Trial +8

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

Cristina Saura, Desamparados Roda, Susana Roselló et al. · Cancer Discovery · 2016 · 167 citations · Full text